DermTech Inc (NAS:DMTK)
$ 0.5701 -0.0679 (-10.64%) Market Cap: 19.93 Mil Enterprise Value: 20.84 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 44/100

DermTech Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 14, 2023 / 02:00PM GMT
Release Date Price: $3.59 (-2.97%)
Frank Brisebois
Oppenheimer & Co. Inc. - Analyst

All right. Thanks for joining. My name is Frank Brisebois. I'm one of the healthcare analysts here at Oppenheimer. Next company to present is DermTech. From the company, we have CEO, John Dobak, to present.

So John, thank you very much. I know it's a little earlier in your time zone, so appreciating the time also. The markets have been pretty entertaining to say the least. So I know it's busy for everyone, so appreciate it. So what we'll do today in terms of format is we do a fireside chat. A lot going on at the company, so I think the timing could be interesting here.

So with that, thank you. And if we could start maybe with just an overview of the company for the listeners that aren't too familiar with DermTech.

John Dobak;Frank Brisebois
DermTech, Inc. - President, CEO & Board Member;Oppenheimer & Co.

Sure. Thanks, Frank. Great to be here. It is early, especially with daylight savings time. So -- but we appreciate the opportunity to participate.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot